Balance Sheet MorphoSys AG Xetra

Equities

MOR

DE0006632003

Biotechnology & Medical Research

Market Closed - Xetra Other stock markets 11:36:08 2024-08-02 am EDT			5-day change	1st Jan Change
67.25 ^EUR	-0.66%		-.--%	+97.79%

Aug. 29	MorphoSys AG Announces Changes in the Composition of the Supervisory Board	CI
Aug. 29	MorphoSys AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI

a6ae3d3ded3489eb8c.MRkRN-yvxdk5znG_hLQHEkN45WLJ3a3f-bi0y2ugIqY.Z3pCdbvN84FDm0n7zuBzaHoc0TOluuiFi8vHg1LEcPFoeE5Egcn0g06mQQ

Published financial data: MORPHOSYS AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	71.76M	328M	180M	278M	238M
Total Revenues	71.76M	328M	180M	278M	238M
Cost of Goods Sold, Total	12.09M	9.17M	32.19M	48.62M	58.35M
Gross Profit	59.67M	319M	147M	230M	180M
Selling General & Admin Expenses, Total	59.34M	159M	182M	153M	147M
R&D Expenses	107M	125M	222M	290M	274M
Other Operating Expenses, Total	166M	285M	404M	442M	421M
Operating Income	-106M	33.98M	-256M	-212M	-241M
Interest Expense, Total	-1.73M	-28.35M	-65.82M	-117M	-110M
Interest And Investment Income	223K	1.23M	723K	4.62M	18.32M
Net Interest Expenses	-1.5M	-27.12M	-65.1M	-112M	-91.54M
Income (Loss) On Equity Invest.	-	-	-	-4.31M	-8.17M
Currency Exchange Gains (Loss)	-180K	65.65M	-25.82M	-34.99M	5.89M
Other Non Operating Income (Expenses)	1.59M	-25.27M	8.21M	389M	135M
EBT, Excl. Unusual Items	-107M	47.24M	-339M	25.79M	-200M
Merger & Related Restructuring Charges	-	-	-19.7M	-	-
Impairment of Goodwill	-	-2.06M	-231M	-	-1.62M
Gain (Loss) On Sale Of Investments	1.67M	-9.1M	-	-	20.63M
Gain (Loss) On Sale Of Assets	-	379K	-	-	-
Asset Writedown	-1.65M	-13.97M	-1.55M	-8.27M	-9.58M
EBT, Incl. Unusual Items	-107M	22.49M	-591M	17.52M	-191M
Income Tax Expense	-3.51M	-75.4M	-76.59M	169M	-1.19M
Earnings From Continuing Operations	-103M	97.89M	-514M	-151M	-190M
Net Income to Company	-103M	97.89M	-514M	-151M	-190M
Net Income - (IS)	-103M	97.89M	-514M	-151M	-190M
Net Income to Common Incl Extra Items	-103M	97.89M	-514M	-151M	-190M
Net Income to Common Excl. Extra Items	-103M	97.89M	-514M	-151M	-190M
Per Share Items
Net EPS - Basic	-3.26	3.01	-15.4	-4.42	-5.53
Basic EPS - Continuing Operations	-3.26	3.01	-15.4	-4.42	-5.53
Basic Weighted Average Shares Outstanding	31.61M	32.53M	33.4M	34.16M	34.31M
Net EPS - Diluted	-3.26	2.97	-15.4	-4.42	-5.53
Diluted EPS - Continuing Operations	-3.26	2.97	-15.4	-4.42	-5.53
Diluted Weighted Average Shares Outstanding	31.61M	33.17M	33.4M	34.16M	34.31M
Normalized Basic EPS	-2.11	0.91	-6.34	0.47	-3.65
Normalized Diluted EPS	-2.11	0.89	-6.34	0.47	-3.65
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	-103M	38.69M	-250M	-206M	-235M
EBITA	-105M	36.14M	-253M	-209M	-238M
EBIT	-106M	33.98M	-256M	-212M	-241M
EBITDAR	-103M	38.78M	-249M	-206M	-235M
Total Revenues (As Reported)	-	-	180M	278M	238M
Effective Tax Rate - (Ratio)	3.29	-335.22	12.96	962.19	0.62
Current Foreign Taxes	-	67.07M	-1.17M	577K	-1.46M
Total Current Taxes	1K	67.07M	-1.17M	577K	-1.46M
Deferred Foreign Taxes	-	-142M	-75.42M	168M	275K
Total Deferred Taxes	-3.51M	-142M	-75.42M	168M	275K
Normalized Net Income	-66.59M	29.53M	-212M	16.12M	-125M
Interest on Long-Term Debt	1.73M	18.96M	33.61M	36.52M	20.8M
Supplemental Operating Expense Items
Selling and Marketing Expenses	22.67M	108M	122M	92.4M	81.37M
General and Administrative Expenses	36.66M	51.4M	58.59M	60.14M	65.8M
Research And Development Expense From Footnotes	108M	141M	225M	298M	284M
Net Rental Expense, Total	41K	81K	1.57M	275K	31K
Imputed Operating Lease Interest Expense	26.58K	102K	870K	150K	15.42K
Imputed Operating Lease Depreciation	14.42K	-20.83K	700K	125K	15.58K
Stock-Based Comp., Other (Total)	6.65M	8.96M	4.28M	6.88M	27.37M
Total Stock-Based Compensation	6.65M	8.96M	4.28M	6.88M	27.37M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	44.31M	110M	123M	402M	158M
Short Term Investments	208M	693M	862M	490M	286M
Trading Asset Securities, Total	20.45M	288M	8.88M	14.62M	234M
Total Cash And Short Term Investments	273M	1.09B	994M	907M	679M
Accounts Receivable, Total	15.08M	83.35M	75.91M	91.23M	32.09M
Other Receivables	1.76M	6.48M	9.88M	21.12M	10.56M
Total Receivables	16.84M	89.84M	85.79M	112M	42.65M
Inventory	288K	9.96M	20.76M	24.25M	62.07M
Prepaid Expenses	14.06M	6.7M	16.82M	45.26M	26.54M
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	-	10M	15.95M	-	4.18M
Total Current Assets	304M	1.21B	1.13B	1.09B	814M
Gross Property Plant And Equipment	66.74M	68.4M	69.86M	71.51M	37.71M
Accumulated Depreciation	-18.93M	-17.66M	-20.27M	-20.52M	-22.72M
Net Property Plant And Equipment	47.81M	50.74M	49.59M	50.99M	14.99M
Long-term Investments	99M	197M	-	5.35M	2.42M
Goodwill	3.68M	1.62M	336M	356M	342M
Other Intangibles, Total	41.12M	69.38M	838M	887M	844M
Deferred Tax Assets Long-Term	-	133M	187M	-	-
Other Long-Term Assets, Total	1.14M	1.57M	13.25M	8.73M	8.48M
Total Assets	496M	1.66B	2.56B	2.4B	2.03B
Liabilities
Accounts Payable, Total	10.66M	47.56M	73.79M	38.58M	28.39M
Accrued Expenses, Total	39.27M	62.92M	97.56M	103M	63.44M
Current Portion of Long-Term Debt	12.32K	423K	88.82M	104M	121M
Current Portion of Leases	2.52M	3.06M	3.24M	7.56M	3.63M
Current Income Taxes Payable	94.73K	65.73M	528K	793K	330K
Unearned Revenue Current, Total	1.57M	2.54M	224K	-	19.44M
Other Current Liabilities	7.44M	18.23M	20.37M	23.74M	27.63M
Total Current Liabilities	61.56M	200M	285M	278M	264M
Long-Term Debt	-	273M	1.45B	1.69B	1.56B
Long-Term Leases	40.04M	41.96M	39.35M	38.22M	8.8M
Unearned Revenue Non Current	115K	71.83K	28.73K	-	-
Deferred Tax Liability Non Current	-	5.06M	22.07M	6.51M	6.55M
Other Non Current Liabilities	23.17K	518M	515M	226M	137M
Total Liabilities	102M	1.04B	2.31B	2.24B	1.98B
Common Stock, Total	31.96M	32.89M	34.23M	34.23M	37.66M
Additional Paid In Capital	628M	749M	833M	834M	938M
Retained Earnings	-256M	-158M	-672M	-823M	-1.01B
Treasury Stock	-8.36M	-4.87M	-3.09M	-2.45M	-2M
Comprehensive Income and Other	-1.3M	2.21M	52.76M	115M	88.44M
Total Common Equity	395M	621M	245M	157M	49.05M
Total Equity	395M	621M	245M	157M	49.05M
Total Liabilities And Equity	496M	1.66B	2.56B	2.4B	2.03B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	32.64M	32.76M	34.15M	34.17M	37.6M
ECS Total Common Shares Outstanding	31.73M	32.76M	34.15M	34.17M	37.6M
Book Value / Share	12.44	18.97	7.17	4.61	1.3
Tangible Book Value	350M	550M	-929M	-1.09B	-1.14B
Tangible Book Value Per Share	11.03	16.8	-27.21	-31.77	-30.25
Total Debt	42.57M	318M	1.58B	1.84B	1.69B
Net Debt	-230M	-772M	588M	933M	1.02B
Debt Equivalent Oper. Leases	328K	648K	12.56M	2.2M	248K
Equity Method Investments, Total	-	-	-	5.35M	2.42M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	-	5.3M	12.1M	13.82M	44.17M
Inventories - Work In Process, Total	-	-	4.1M	-	-
Inventories - Finished Goods, Total	-	4.66M	4.56M	10.43M	25.3M
Machinery, Total	20.78M	23.98M	27.38M	26.45M	26.61M
Full Time Employees	426	615	732	629	524
Accumulated Allowance for Doubtful Accounts (Supple)	80K	424K	360K	414K	166K

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-103M	97.89M	-514M	-151M	-190M
Depreciation & Amortization - CF	4.75M	6.09M	6.46M	6.95M	6.92M
Amortization of Goodwill and Intangible Assets - (CF)	1.28M	2.16M	3.53M	3.5M	3.53M
Depreciation & Amortization, Total	6.03M	8.25M	10M	10.45M	10.45M
Amortization of Deferred Charges, Total - (CF)	211K	81K	94K	86K	81K
(Gain) Loss From Sale Of Asset	-21.41K	-379K	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-918K	-14.07M	-19.7M	-304M	-132M
Asset Writedown & Restructuring Costs	2.32M	16.48M	236M	7.81M	26.53M
(Income) Loss On Equity Investments - (CF)	-	-	-	-15.57M	3.94M
Stock-Based Compensation (CF)	6.65M	8.96M	2.59M	3.64M	27.37M
Other Operating Activities, Total	-9.23M	-94.77M	-82.88M	134M	-49.99M
Change In Accounts Receivable	2.67M	-69.62M	10.53M	-18.17M	56.87M
Change In Inventories	-	-8.49M	-30.35M	-	-
Change In Accounts Payable	13.2M	77.51M	-90.82M	-21.09M	-44.28M
Change in Unearned Revenues	6.07M	13.43M	-2.36M	-253K	19.44M
Change In Income Taxes	-	-	-	-11.92M	-24.83M
Change in Other Net Operating Assets	-4.11M	-	-	-	-
Cash from Operations	-80.14M	35.27M	-481M	-367M	-296M
Capital Expenditure	-3.1M	-4.46M	-3.81M	-1.93M	-349K
Sale of Property, Plant, and Equipment	20.47K	-	-	-	-
Cash Acquisitions	-	-	-1.21B	-	-
Divestitures	-	2.48M	-	-	-
Sale (Purchase) of Intangible assets	-562K	-44.88M	-22.35M	-13.3M	-2.52M
Investment in Marketable and Equity Securities, Total	82.11M	-830M	404M	356M	72.52K
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	90.16K	-2.65M	-1.88M	4.44M	18.17M
Cash from Investing	78.55M	-880M	-831M	345M	15.37M
Long-Term Debt Issued, Total	3.71M	321M	-	-	-
Total Debt Issued	3.71M	321M	-	-	-
Long-Term Debt Repaid, Total	-2.35M	-2.79M	-3.13M	-3.41M	-48.28M
Total Debt Repaid	-2.35M	-2.79M	-3.13M	-3.41M	-48.28M
Issuance of Common Stock	-	80.6M	84.97M	-	103M
Repurchase of Common Stock	-	-	-	-	-
Other Financing Activities, Total	-1.01M	509M	1.24B	315M	-11.42M
Cash from Financing	353K	907M	1.32B	311M	43M
Foreign Exchange Rate Adjustments	87.12K	3.4M	2.99M	-10.61M	-6.39M
Miscellaneous Cash Flow Adjustments	-	-750K	-	-	-
Net Change in Cash	-1.15M	65.48M	13.45M	279M	-244M
Supplemental Items
Cash Interest Paid	1.01M	1.43M	4.74M	4.37M	1.84M
Cash Income Tax Paid (Refund)	62.56K	304K	64.61M	466K	1.64M
Levered Free Cash Flow	-46.52M	24.11M	-240M	-255M	-165M
Unlevered Free Cash Flow	-45.44M	41.82M	-199M	-182M	-96.69M
Change In Net Working Capital	-11.86M	-52.64M	27.31M	51.72M	-19.07M
Net Debt Issued / Repaid	1.36M	318M	-3.13M	-3.41M	-48.28M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-12.85	1.97	-7.6	-5.36	-6.82
Return on Total Capital	-14.37	3.08	-11.58	-6.94	-8.06
Return On Equity %	-23.33	19.27	-118.79	-75.1	-183.8
Return on Common Equity	-23.33	19.27	-118.79	-75.1	-183.8
Margin Analysis
Gross Profit Margin %	83.16	97.2	82.08	82.53	75.51
SG&A Margin	82.69	48.56	101.17	54.82	61.76
EBITDA Margin %	-143.85	11.81	-139.23	-74	-98.8
EBITA Margin %	-146.56	11.03	-140.77	-75.09	-99.77
EBIT Margin %	-148.35	10.37	-142.74	-76.34	-101.26
Income From Continuing Operations Margin %	-143.56	29.87	-286.43	-54.29	-79.63
Net Income Margin %	-143.56	29.87	-286.43	-54.29	-79.63
Net Avail. For Common Margin %	-143.56	29.87	-286.43	-54.29	-79.63
Normalized Net Income Margin	-92.8	9.01	-117.99	5.79	-52.55
Levered Free Cash Flow Margin	-64.83	7.36	-133.89	-91.69	-69.39
Unlevered Free Cash Flow Margin	-63.32	12.76	-110.98	-65.52	-40.58
Asset Turnover
Asset Turnover	0.14	0.3	0.09	0.11	0.11
Fixed Assets Turnover	2.8	6.65	3.58	5.53	7.22
Receivables Turnover (Average Receivables)	4.37	6.66	2.26	3.33	3.86
Inventory Turnover (Average Inventory)	45.32	1.79	2.1	2.16	1.35
Short Term Liquidity
Current Ratio	4.93	6.02	3.98	3.91	3.08
Quick Ratio	4.7	5.89	3.79	3.66	2.73
Operating Cash Flow to Current Liabilities	-1.3	0.18	-1.69	-1.32	-1.12
Days Sales Outstanding (Average Receivables)	83.46	54.97	161.83	109.62